GlassScriptPhysician profile
Pinhas Geva
NPI 1093885394
$1,173.23
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $867 · 2020: $290 · 2021: $16.14.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $300.75 | 2019-2020 | |
| Novo Nordisk INC | $145.22 | 2019-2020 | |
| Medtronic Minimed, INC. | $135.48 | 2019-2020 | |
| Genzyme Corporation | $117.99 | 2019 | |
| Insulet Corporation | $107.37 | 2019-2020 | |
| Fresenius Kabi USA, LLC | $85.49 | 2019 | |
| Tandem Diabetes Care, INC. | $42.77 | 2019-2020 | |
| Phadia US INC. | $41.79 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $37.60 | 2019-2020 | |
| Lilly USA, LLC | $37.04 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $35.24 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $21.99 | 2020 | |
| Xeris Pharmaceuticals, INC. | $18.69 | 2020 | |
| Qol Medical, LLC | $16.14 | 2021 | |
| Dexcom, INC. | $16.12 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $13.55 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pinhas Geva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.